Proximal Interphalangeal Joint Arthroplasty Using a Graft From the Capitate
NCT ID: NCT01479738
Last Updated: 2011-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2005-01-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Capitate bone grafting
18 patients with PIP joint defects were included in the study. There were 13 male and 5 female patients with a mean age of 31 years (range, 18-47 years). The injury occurred in the right hand in 11 patients and on the left hand in 7. The injured PIP joints were in the index finger (n=7), long finger (n=9), and ring finger (n=2).
Capitate bone grafting
Capitate bone graft transfer for PIP joint reconstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capitate bone grafting
Capitate bone graft transfer for PIP joint reconstruction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. the defect larger than 5 mm × 5 mm in size based on intraoperative findings.
Exclusion Criteria
2. the size of the defect less than 5 mm × 5 mm;
3. mult-digital articular defects that all required osteoarticular grafting;
4. associate with infection or other diseases that restrict to use the technique.
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Second Hospital of Qinhuangdao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xu Zhang, M.D.
Role: STUDY_CHAIR
The Second Hospital of Qinhuangdao
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The second hospital of Qinhuangdao
Qinhuangdao, Hebei, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Freiberg A. Management of proximal interphalangeal joint injuries. Can J Plast Surg. 2007 Winter;15(4):199-203. doi: 10.1177/229255030701500407.
Related Links
Access external resources that provide additional context or updates about the study.
Management of proximal interphalangeal joint injuries
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHQ002
Identifier Type: -
Identifier Source: org_study_id